Bizarre Patents
A method of swing on a swing is disclosed, in which a user positioned on a standard swing suspended by two chains from a substantially horizontal tree branch induces side to side motion by pulling alternately on one chain and then the other.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7419962 | 3,6-bicyclolides The present invention discloses compounds of formula (I) or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical com... | 09/02/2008 |
| 7414030 | 6-11 Bicyclic erythromycin derivatives The present invention discloses compounds of formulaes I, II, III, or IV, or a racemate, enantiomer, regioisomer, salt, ester or prodrug thereof: which exhibit antibacterial properties. The present invention further relates... | 08/19/2008 |
| 7407942 | 3,6-bridged 9,12-oxolides The present invention discloses compounds of formula (I) or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical com... | 08/05/2008 |
| 7365056 | Substituted 9a-N-(N′-(sulfonyl)phenylcarbamoyl)derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerithomycin A and 5-0-desosaminyl-9-deoxo-9-dihydro-9-a-aza-9a-homoerithronolide A The invention relates to substituted 9a-N-{N′-[4-(sulfonyl)phenyl]carbamoyl} derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerithromycin A and 5-0-desosaminyl-9-deoxo-9-di-hydro-9a-aza-9a-homoerithronolide A, novel semisynthetic macrolide antibiotics of the azalid... | 04/29/2008 |
| 7291602 | 11,12-lactone bicyclolides The present invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmace... | 11/06/2007 |
| 7229972 | 3,6-Bicyclolides The present invention discloses compounds of formula (I) or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmac... | 06/12/2007 |
| RE39383 | Process for 6-O-alkylation of erythromycin derivatives A procedure for preparing 6-O-alkyl erythromycin compounds having the formula: wherein R1 is a loweralkyl group, R2 and R3 an independently hydrogen or a hydroxy-protecting group, except that R | 11/07/2006 |
| 7074932 | Preparation of quinoline-substituted carbonate and carbamate derivatives The invention relates to a process for preparing quinoline-substituted carbonate and carbamate compounds, which are important intermediates in the synthesis of 6-O-substituted macrolide antibiotics. The process employs metal-catalyzed coupling reactions to provide a... | 07/11/2006 |
| 7071170 | Macrolide antibiotics This invention relates to compounds of the formula wherein a, R1, R2, R3, R4, R5, R6 and X are each as defined above, and to pharmaceutically acce... | 07/04/2006 |
| 7049417 | 6,11-4-Carbon bridged ketolides Novel 6,11-4-carbon bridged ketolides, pharmaceutically-acceptable compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically-acceptable carrier are described. Also described are a method for trea... | 05/23/2006 |
| 7015203 | Macrolides The invention relates to novel erythromycin analogs and azalides, particularly ones with novel C-13 substituents, and to pharmaceutically acceptable salts thereof. The compounds of this invention are antibacterial agents that may be used to treat various bacterial a... | 03/21/2006 |
| 6998390 | Oxolide antibacterials Antibacterial compounds having formula (I) and formula (II) and salts, prodrugs, and salts of prodrugs thereof, processes for making the compounds and intermediates employe... | 02/14/2006 |
| 6995143 | Macrolides with antibacterial activity The invention provides new macrolides antibiotics of formula I with improved biological properties and having the formula wherein R1, R2 and R3 are as herein described. ... | 02/07/2006 |
| 6953782 | 11-C-substituted erythromycin derivatives The present invention discloses compounds of formulae I, II, III or IV or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to... | 10/11/2005 |
| 6946446 | Anti-infective agents useful against multidrug-resistant strains of bacteria The invention relates to novel methods for using macrolide anti-infective agents. The macrolide anti-infective agents demonstrate antibacterial activity against multi-drug resistant strains of bacteria and, in particular, methicillin-resistant Staphylococcus aure... | 09/20/2005 |
| 6933283 | 11-deoxy azalide antibacterials Antibacterial compounds having formula (I) and formula (II) and salts, prodrugs, and salts of prodrugs thereof, processes for making the compounds and intermediates used ... | 08/23/2005 |
| 6900183 | Macrolide antibiotics 11,12 γ lactone ketolides of the following formula: and pharmaceutically acceptable salts and solvates thereof, wherein R, R1, R2, and R3 are as described herein. The disclosure also r... | 05/31/2005 |
| 6872707 | Halo derivatives of 9-deoxo-9a-aza-homerythromycin A The invention relates to halo derivatives of 9a-N-(N′-arylcarbamoyl)- and 9a-N-(N′-arylthiocarbamoyl)-9-deoxo-9a-aza-9a-homoerythromycin A of the general formula (I) wherein R has the meaning of a substituted aryl ... | 03/29/2005 |
| 6852702 | 9a-N-[N′-(phenylsulfonyl)carbamoyl] derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin A and of 5-O-desosaminyl-9-deoxo-9-dihydro-9a-aza-9a-homoerythronolide A 9a-N-[N′-(phenylsulfonyl)carbamoyl] derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin A and of 5-O-desosaminyl-9-deoxo-9-dihydro-9a-aza-9a-homoerythronolide A and their pharmaceutically acceptable addition salts with inorganic or organic acids are provid... | 02/08/2005 |
| 6849608 | Macrolide antibiotics A macrolide antibiotic of the formula wherein the variables are defined as described herein. ... | 02/01/2005 |
| 6841664 | 6,11-4-carbon bridged ketolides Novel 6,11-4-carbon bridged ketolides, pharmaceutically-acceptable compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically-acceptable carrier are described. Also described are a method for trea... | 01/11/2005 |
| 6825172 | 3-descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents 3-Descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents of the formula: wherein R1, W, R3, R4, R5, R6, X, X′, and Z are as described herei... | 11/30/2004 |
| 6825171 | Erythromycin derivatives The invention relates to novel erythromycin derivatives, particularly ones with novel C-13 R13 substitutents, and to pharmaceutically acceptable salts thereof. The compounds of this invention are useful as antibacterial agents and antiprotozoa agents and ... | 11/30/2004 |
| 6812216 | 11-C-substituted derivatives of clarithromycin There are described 11-C-substituted derivatives of clarithromycin and pharmaceutically acceptable compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier. Also described is ... | 11/02/2004 |
| 6809188 | Method of preparing clarithromycin Clarithromycin can be easily prepared by reacting erythromycin A N-oxide with a methylating agent to obtain 6-O-methylerythromycin A N-oxide; and treating 6-O-methylerythromycin A N-oxide obtained above with a reducing agent in a high yield. ... | 10/26/2004 |
| 6790835 | Bicyclic macrolide derivatives The present invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical c... | 09/14/2004 |
| 6777543 | 13-methyl erythromycin derivatives The invention relates to compounds of the formula and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein R1, R2, R3, R4, R5, R17... | 08/17/2004 |
| 6774115 | 6-O-substituted bicyclic ketolides The present invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical c... | 08/10/2004 |
| 6767998 | Method for preparing purified erythromycin The object of the present invention is to prepare purified erythromycin by removing erythromycin F from erythromycin. The present invention provides a method for preparing purified erythromycin from which erythromycin F is removed, which comprises the step of... | 07/27/2004 |
| 6764998 | 6,11-4C-bicyclic 9a-azalide derivatives The present invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical c... | 07/20/2004 |
| 6756359 | C12 modified erythromycin macrolides and ketolides having antibacterial activity Antimicrobial macrolide compounds are provided having formulas II: as well as pharmaceutically acceptable salts, esters or prodrugs thereof; pharmaceutical compositions comprising such compounds; methods of treating bact... | 06/29/2004 |
| 6753318 | 6,11-4-carbon bridged erythromycin derivatives Novel 6,11-4-carbon bridged erythromycin derivatives and pharmaceutically-acceptable compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically-acceptable carrier are described. Also described are... | 06/22/2004 |
| 6740642 | Macrolides with antibacterial activity The invention provides new macrolides antibiotics of formula I with improved biological properties and improved stability of the formula wherein R1 is hydrogen, cyano, —S(L)mR2, ... | 05/25/2004 |
| 6734292 | Pseudoerythromycin derivatives The present invention is to obtain novel anti-inflammatory agents having decreased antibacterial activity and increased anti-inflammatory action, and is psedoerythromycin derivatives represented by the following general formula [I], | 05/11/2004 |
| 6727229 | 11,12-substituted lactone ketolide derivatives having antibacterial activity Novel 11-12 substituted lactone ketolide derivatives and pharmaceutically-acceptable compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically-acceptable carrier are described. Also described are... | 04/27/2004 |
| 6720308 | Anhydrolide derivatives having antibacterial activity Novel 11-12 substituted lactone anhydrolide derivatives and pharmaceutically-acceptable compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically-acceptable carrier are described. Also described ... | 04/13/2004 |
| 6713615 | Process for producing erythromycin derivative There is provided a preparation process useful for an efficient synthesis of 6-O-substituted ketolide derivatives by combining a characterized step of introduction of a substituent at the 6-position by selective cleavage of a C—O bond of the cyclic acetal at the 9... | 03/30/2004 |
| 6642364 | Process to obtain clarithromycin This process is intended to obtain clarithromycin. According to the process, it starts from the erythromycin A 9-oxime hydrochloride, which is transformed into clarithromycin by means of a synthetic sequence in which an acetal of the 9-oxime is initially ... | 11/04/2003 |
| 6600025 | Intermediates, process for preparing macrolide antibiotic agent therefrom An erythromycin A 9-O-benzodithiol oxime intermediate represented by the following formula (III) useful for synthesis of clarthromycin and crystalline solvate thereof: ##STR1## Wherein, Y1 and Y2 are independently a hydrogen atoms or... | 07/29/2003 |
| 6455680 | Methods utilizing aryl thioimines in synthesis of erythromycin derivatives An efficient deoximation technique for use in synthesis of erythromycin derivatives, involving aryl thioimine intermediates is disclosed. The aryl thioimine intermediates can be utilized in a method for protecting a ketone of a ketone-containing erythromy... | 09/24/2002 |
